PlainRecalls
FDA Drug Moderate Class II Terminated

Glycopyrrolate Tablets, USP 1 mg, 100-count bottle, Rx only, Dist. by: Par Pharmaceutical, Chestnut Ridge, NY, 10977, U.S.A, Mfg. by: Par Formulations Private Limited, 1/58, Pudupakkam, Kelambakkam - 603 103., Made in India NDC# 49884-0065-01

Reported: April 8, 2020 Initiated: March 30, 2020 #D-1071-2020

Product Description

Glycopyrrolate Tablets, USP 1 mg, 100-count bottle, Rx only, Dist. by: Par Pharmaceutical, Chestnut Ridge, NY, 10977, U.S.A, Mfg. by: Par Formulations Private Limited, 1/58, Pudupakkam, Kelambakkam - 603 103., Made in India NDC# 49884-0065-01

Reason for Recall

Failed Impurities/Degradation Specification: Presence of unknown impurity observed.

Details

Recalling Firm
Par Pharmaceutical Inc.
Units Affected
29,352 bottles
Distribution
Product was distributed within the United States.
Location
Chestnut Ridge, NY

Frequently Asked Questions

What product was recalled?
Glycopyrrolate Tablets, USP 1 mg, 100-count bottle, Rx only, Dist. by: Par Pharmaceutical, Chestnut Ridge, NY, 10977, U.S.A, Mfg. by: Par Formulations Private Limited, 1/58, Pudupakkam, Kelambakkam - 603 103., Made in India NDC# 49884-0065-01. Recalled by Par Pharmaceutical Inc.. Units affected: 29,352 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specification: Presence of unknown impurity observed.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 8, 2020. Severity: Moderate. Recall number: D-1071-2020.